Alternative Methods in Neurotoxicology (Volume 9) (Advances in Neurotoxicology, Volume 9) - Hardcover

Über die Autorinnen und Autoren

Dr. Rocha serves as full professor of toxicological biochemistry at the Departament of Biochemistry and Molecular Biology in the Center of Natural and Exact Sciences, FederaL University of Rio Grande do Sul, Brazil. He researches areas include the use of alternative invertebrate models in neurotoxicology and the interaction of mercury forms with the selenol group of selenoproteins and low-molecular mass selenium-containing molecules One important subtopic focused in the interaction of methylmercury and Hg2+ with thiol- and selenol-containing molecules both in silico and in vitro. The main aims of in vitro studies are to determine how mercury disrupt the thiol- and selenol-containing proteins in the nervous system of invertebrates. The in silico studies aims are to develop chemical and biochemical models to predict how electrophilic mercury forms can disrupt the function of thiol- and selenol-containing proteins. Specially, on how the interaction of Hg forms can impair the cell redox environment by inactivating or sequestering the trace element selenium. He has authored (co-authored) >500 peer reviewed manuscripts and 20 book chapter and is associated editor of Neurotoxicology and the Journal of Animal Physiology and Animal Nutrition.

Dr. Michael Aschner is currently the Harold and Muriel Block Chair in Molecular Pharmacology at Albert Einstein College of Medicine where he is also a Professor in the Departments of Molecular Pharmacology, Neuroscience, and Pediatrics. He is a leading expert in neurotoxicology and neurodevelopmental and neurodegenerative diseases. In addition to serving as a past president of the Society of Toxicology (2022-23), he served on numerous toxicology panels (U.S. EPA and CDC), been an expert reviewer for multiple federal agencies in the US and abroad, and is a member of the Neurotoxicology and Alcohol study section (NIH). He is a past recipient of the prestigious Society of Toxicology Merit Award (2010) and the Distinguished Neurotoxicologist Award (2020). He is a co-editor of the Elsevier series, Advancements in Neurotoxicology in addition to edited other Elsevier titles. He has published numerous articles and has served as an associate editor for multiple high impact factor journals.

Dr. Lucio G. Costa is Professor of Toxicology at the University of Washington in Seattle, and of Pharmacology/Toxicology at the University of Parma Medical School. He received a doctorate in Pharmacology from the University of Milano in 1977, and was a postdoctoral fellow at the University of Texas at Houston. He is a member of several national and international professional organizations, a Fellow of the Academy of Toxicological Sciences, and a European Certified Toxicologist. He received various award for his scientific accomplishments, including the Achievement Award from the Society of Toxicology. He serves in various editorial capacities for several toxicology journals, and is an active manuscript and grant reviewer. Dr. Costa has been the member of dozens of panels and committees at the national and international level dealing with toxicology and risk assessment issues. He has chaired and/or organized symposia at scientific meetings in the United States and internationally. He has been teaching classes in the area of toxicology, neurotoxicology and pharmacology to graduate and medical students for 30 years. He keeps an active research program in the area of neurotoxicology.

Von der hinteren Coverseite

The volume Alternative Methods in Neurotoxicology to be published in the Advances in Neurotoxicology series will give you an overview of important in vitro and non-vertebrate animal models available to study the neurotoxicity of a range of toxicants of occupational and environmental relevance. The evaluation of neurotoxicity will include behavioral, morphological, cellular, subcellular and molecular end-points. The volume will covers the most popular non-vertebrate organism (Drosophila melanogaster and C. elegans) as well as new emerging invetebrates. The in vitro methodologies will include the use of human stem cells and neurospheres in developmental neurotoxicology.